TEM vs TMO · rev $1.27B vs P/E 24, rev $44.56B
Tempus AI, Inc. Class A Common Stock (TEM) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Tempus AI, Inc. Class A Common Stock (TEM) is a health information services company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported TEM revenue for 2025-12-31 was $1.27B. Net income was -$245.0M. Revenue was up 83.4% from 2024-12-31 to 2025-12-31. TEM currently screens at market cap $8.76B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
TEM currently screens at market cap $8.76B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the TEM and TMO stock pages for the full models.
Not investment advice.